Literature DB >> 6300453

Binding of human interferon alpha to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity.

S Yonehara, M Yonehara-Takahashi, A Ishii.   

Abstract

The characteristics of interferon binding to various cells with different interferon sensitivity were studied by using [3H]leucine-labeled, pure human interferon alpha from Namalwa cells. Scatchard analysis of the binding data on cells sensitive to interferon alpha (human FL and fibroblasts and bovine MDBK) indicated the presence of two kinds of binding sites with high and low affinities. The binding constants of the high-affinity sites in these cells were similar (4 X 10(10) to 11 X 10(10) M-1). Cells insensitive to human interferon alpha (human HEC-1 and mouse L cells) were shown to have only low-affinity sites, suggesting that high-affinity binding sites are indispensable for interferon sensitivity and represent interferon receptors. However, the number of sites in three human diploid fibroblast strains and one strain trisomic for chromosome 21 were not proportionally correlated to the interferon sensitivity of the cells. The high-affinity binding to human cells was completely inhibited by both nonradioactive human interferons alpha and beta in a similar manner, but binding to bovine MDBK cells, on which human interferon beta is practically inactive, was inhibited effectively only by interferon alpha and not by beta. These results suggest that the receptor for human interferon alpha is common to human interferon beta in human cells, whereas the receptor on bovine cells binds only human interferon alpha.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300453      PMCID: PMC256528     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon.

Authors:  M Revel; D Bash; F H Ruddle
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

2.  Interferon externalization by producing cell before induction of antiviral state.

Authors:  V E Vengris; B D Stollar; P M Pitha
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

3.  Somatic cell genetic analysis of the interferon system.

Authors:  R P Creagan; Y H Tan; S Chen; F H Ruddle
Journal:  Fed Proc       Date:  1975-12

4.  Insulin interactions with its receptors: experimental evidence for negative cooperativity.

Authors:  P de Meyts; J Roth; D M Neville; J R Gavin; M A Lesniak
Journal:  Biochem Biophys Res Commun       Date:  1973-11-01       Impact factor: 3.575

5.  Properties of the specific binding of 125I-nerve growth factor to responsive peripheral neurons.

Authors:  W A Frazier; L F Boyd; R A Bradshaw
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

6.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

7.  The binding of thyrotropin to isolated bovine thyroid plasma membranes.

Authors:  S M Amir; T F Carraway; L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

8.  Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.

Authors:  Y H Tan; E L Schneider; J Tischfield; C J Epstein; F H Ruddle
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

9.  Antiviral effect of interferon covalently bound to sepharose.

Authors:  H Ankel; C Chany; B Galliot; M J Chevalier; M Robert
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

10.  The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21.

Authors:  Y H Tan; J Tischfield; F H Ruddle
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  12 in total

1.  Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Authors:  Yuhki Yamaguchi; Keisuke Hino; Daisuke Fujiwara; Fenyu Ren; Yoshiharu Katoh; Yasuhiro Satoh; Kiwamu Okita
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  Neutralization of activity of effector protein by monoclonal antibody: formulation of antibody dose-dependence of neutralization for an equilibrium system of antibody, effector, and its cellular receptor.

Authors:  Y Kawade
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

Review 3.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Interferon receptors.

Authors:  A A Branca
Journal:  In Vitro Cell Dev Biol       Date:  1988-03

5.  Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus.

Authors:  M Crespi; M N Chiu; J K Struthers; B D Schoub; S F Lyons
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.

Authors:  R Fukuda; N Ishimura; S Ishihara; A Tokuda; S Satoh; S Sakai; S Akagi; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

7.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.

Authors:  S Pellegrini; J John; M Shearer; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

Review 8.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

9.  Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells.

Authors:  E C O'Rourke; R J Drummond; A A Creasey
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

10.  Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

Authors:  Y Numa; K Kawamoto; N Sakai; H Matsumura
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.